CRYO-CELL INTERNATIONAL, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $6.93 million for the 3-month period ending 2015-08-31, per its 10-Q filed 2016-10-17.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2016-10-17
- CRYO-CELL INTERNATIONAL, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2015-08-31 was $6.93M.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month |
|---|---|---|
| 2015-08-31 | $6.93M 10-Q · filed 2016-10-17 | $6.88M 10-Q · filed 2016-10-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |